506
Views
7
CrossRef citations to date
0
Altmetric
Original

Characterization of the Pro-Thrombotic State in CAPD Patients

, , &
Pages 597-602 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wenning Li, Wen Chen, Maowei Xie, Haiyang Huang, Huiluan Su, Hui Han, Daofa Zhang, Ying Zhang, Xiaohong Yang, Wentan Xu, Yan Su, Wei Wu, Yun Huang, Keying Fu & Jiali Wei. (2016) Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients. Renal Failure 38:9, pages 1359-1363.
Read now

Articles from other publishers (6)

Ya‐Juan Huang, Li‐Ping Xiong, Xing Zhang, Jia‐Fan Zhou & Rui Zhang. (2023) Higher D‐dimer and activated partial thromboplastin time are poor prognostic factors in patients with peritoneal dialysis‐related peritonitis. Therapeutic Apheresis and Dialysis.
Crossref
Hua Zheng, Haiyun Wang, Zijuan Zhou, Huacong Cai, Jing Liang, Yan Qin, Peng Xia & Limeng Chen. (2022) End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series. Kidney International Reports 7:12, pages 2639-2646.
Crossref
Menso J. Nubé & Auguste Sturk. 2016. Hemodiafiltration. Hemodiafiltration 183 195 .
Jens Lutz, Julia Menke, Daniel Sollinger, Helmut Schinzel & Klaus Thürmel. (2014) Haemostasis in chronic kidney disease. Nephrology Dialysis Transplantation 29:1, pages 29-40.
Crossref
Krystyna Pawlak, Michal Mysliwiec & Dariusz Pawlak. (2010) Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients. Thrombosis Research 125:2, pages e40-e45.
Crossref
Goran Pante Koracevic. (2009) Pragmatic classification of the causes of high D-dimer. The American Journal of Emergency Medicine 27:8, pages 1016.e5-1016.e7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.